Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as against Rs 0.42 crore during the previous quarter ended June 2023. Sales declined 84.23% to Rs 3.18 crore in the quarter ended June 2024 as against Rs 20.16 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	3.18	20.16	-84
OPM %	25.79	1.69	-
PBDT	1.48	0.89	66
PBT	0.81	0.43	88
NP	0.49	0.42	17